Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ0113 in Early-Onset Parkinson's Disease
NCT07741045Phase 3Not yet recruiting
- Sponsor
- Phecda Medicine
- Start
- Aug 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 3 trial of TJ0113 in Parkinson's disease (PD), sponsored by Phecda Medicine. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
TJ0113
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07741045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741045.